Abstract

Mechanical circulatory support (MCS) devices, such as the total artificial heart and ventricular assist devices, are employed as bridge-to-transplant or destination therapies for advanced heart failure.[1] Recipients of these life-saving MCS devices have to endure life-long antiplatelet regimens to counteract thromboembolic events resulting from exposure of platelets to high shear stress. Often, large animal models, i.e. bovine and ovine, have been utilized to evaluate the performance and blood compatibility of these cardiovascular devices. Therefore, understanding and correlating the interspecies differences of platelet reactivity is crucial in optimizing the design of MCS devices.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.